Utah Medical Products Inc
UTMD· Nasdaq
Released Oct 25, 2022, during market hours
10-Q filed Nov 10, 2022, 41 days after period end · 0001811884-22-000015
| Metric | Q3 2022 | Q3 2021 | Q3 2020 | Q3 2019 |
|---|---|---|---|---|
| Revenue | $12.96M | $12.57M | $10.48M | $12.49M |
| Net Income | $4.28M | $4.21M | $2.93M | $3.71M |
| EPS Diluted |
Utah Medical Products Inc · CIK 706698 · Engraved from SEC EDGAR
| $1.18 |
| $1.15 |
| $0.80 |
| $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.